Thomas Mayr

3PUBLICATIONS
13CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Oct 29, 2025
Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19.

A Dette, F Moers, T Mayr

|May 25, 2024
Neuropilin2 in Mesenchymal Stromal Cells as a Potential Novel Therapeutic Target in Myelofibrosis.

Karla Vosbeck, Sarah Förster, Thomas Mayr

|Sep 23, 2022
Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.

Yuri Tolkach, Anika Kremer, Gábor Lotz

Pageof 1

Frequent Collaborators

2 joint publications

Ines Gütgemann

1 joint publications

A Dette

1 joint publications

Anika Kremer

1 joint publications

Gábor Lotz

1 joint publications

Stephan Garbe

1 joint publications

Sana Hosni

1 joint publications

Éva Kocsmár

1 joint publications

Manuel Ritter

1 joint publications

Jörg Ellinger

1 joint publications

Anshupa Sahu

Frequent Collaborators

2 joint publications

Ines Gütgemann

1 joint publications

A Dette

1 joint publications

Anika Kremer

1 joint publications

Gábor Lotz

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.6K
An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on : Aug 23, 2016

10.0K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on : Nov 19, 2019

6.9K
See more related videos

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.6K
An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
07:43

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on : Aug 23, 2016

10.0K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on : Nov 19, 2019

6.9K
See more related videos